Molecular carcinogenesisHumansCore Binding Factor Alpha 2 SubunitLeukemiaMyeloidAcute
Identification of a Novel RUNX1::HMGN1 Fusion in Therapy Acute Myeloid Leukemia.
Li Fen, Qin Tao, Zhao Jie, Lv Mingen, Yang Guanqun, Hu Peng, Zhang Qin, Wang Zheng
Published: 202610.1002/mc.70062
Abstract
Therapy acute myeloid leukemia (AML) is a heterogeneous malignant hematopoietic disease that arises either from an antecedent hematologic disorder, including myelodysplastic syndromes, myeloproliferative neoplasms, aplastic anemia, or as a result of…
Preview only. Read the full abstract at the source